Table 2. Disposition of patients across different cohorts.

Baseline characteristics
	10/600 (n=3)	20/600 (n=4)	20/800 (n=4)	40/600 (n=4)	40/800 (n=6)	100/600 (n=13)	200/600 (n=6)	Total (n=40)
Refractory solid tumour, n (%)	3 (100)	4 (100)	0	4 (100)	0	3 (23.1)	6 (100)	20 (50)
First-line melanoma, n (%)	0	0	4 (100)	0	6 (100)	10 (76.9)	0	20 (50)
Malignant melanoma, NOS, n (%)	3 (100)	1 (25)	4 (100)	1 (25)	6 (100)	12 (92.3)	3 (50)	30 (75)
Other, n (%)	0	3 (75)	0	3 (75)	0	1 (7.7)	3 (50)	10 (25)

Abbreviation: NOS=not otherwise specified.